Once in production i would be looking at well, well past a $1.
GF will not want to make a move before the plant is constructed, proven and working well. It would be worth paying the extra but still getting it dirt cheap given the importance of Goulamina to the future of GF.
GF will not likely want to do anything that puts at risk the planned production schedule.
I think its a matter of toughing it out until the product is flying off the production line.
I also think that GF would be taking the lead in Mali discussions peed off big time that they bought into the old mining law in good faith and Mali is trying to bend them and the project over.
The discussions will not be over until GF as senior partner says they are. In the meantime there is no way LLL will release any information concerning negotiations unless they want to completely ruin the LLL/GF relationship and the value of our holdings.
LLL are just playing the 'team game' by not releasing sensitive information.
- Forums
- ASX - By Stock
- LLL
- General Discussion
General Discussion, page-8801
-
- There are more pages in this discussion • 1,850 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LLL (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $605.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LLL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online